Another shiny day here on the Pharmalot corporate campus, where this is much to do. You know the drill - meetings, deadlines and a blizzard of emails. Nonetheless, our spirits are equally sunny. So as prepare the required cup of stimulation, join us as we sift through the news of the world. Have a great day and do stay in touch...
King Pharmaceuticals Profit Falls Short (Reuters)
Aftermath Of The Intermune Debacle (TheStreet)
KV Pharma Gets A Positive Manufacturing Review (Reuters)
Covance Cuts Guidance On Late-Stage Delays (OutsourcingPharma)
J&J Failed To Safeguard Children's Tylenol (Bloomberg News)
Merck And Ariad Restructure Agreement (MarketWatch)
Drugmakers Agree To Cut Australia's Drug Bill (Bloomberg News)
Bristol-Myers To Repurchase $3B In Stock (Associated Press)